Federal grants to Emocha Mobile Health Inc
Emocha Mobile Health Inc in Owings Mills, Maryland received $6.1 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cardiovascular Diseases Research, with $3.6 million. In fiscal 2025 it was awarded $1.3 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$6.1 million
- Awards4
- Awarded in FY 2025$1.3 million
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $728,484 |
| FY 2022 | 0 | -$2,498 |
| FY 2023 | 3 | $2.0 million |
| FY 2024 | 3 | $2.1 million |
| FY 2025 | 2 | $1.3 million |
Programs that fund Emocha Mobile Health Inc
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 2 | $3.6 million |
| Drug Use and Addiction Research Programs | 1 | $1.9 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $691,490 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $6.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program - project summary the COVID-19 pandemic intersecting with the opioid epidemic led to dramatic shifts in the delivery of care for opioid use disorders | Drug Use and Addiction Research Programs | August 1, 2023 | $2.0 million |
| Adhere (applying directly observed therapy to hydroxyurea to realize effectiveness) - summary/abstract: sickle cell disease (SCD) is a severe inherited blood disorder that leads to frequent acute and costly long-term complications. Hydroxyurea is the primary scd modifying medication in childhood bec | Cardiovascular Diseases Research | September 6, 2023 | $1.9 million |
| Evaluation of a mobile app-based video directly observed therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients - few interventions have proven to be successful in promoting medication adherence and impacting short- and long-term posttransplant outcomes in a | Cardiovascular Diseases Research | March 31, 2023 | $1.7 million |
| Development and evaluation of a mobile directly observed therapy smartphone app for immunosuppressive adherence in transplant patients | Diabetes, Digestive, and Kidney Diseases Extramural Research | May 27, 2021 | $691,490 |
Questions people ask
How much federal grant money does Emocha Mobile Health Inc get?
$6.1 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Emocha Mobile Health Inc the most?
The Department of Health and Human Services, with $6.1 million in 4 awards.
What is Emocha Mobile Health Inc's largest federal grant?
$2.0 million under Drug Use and Addiction Research Programs, with its first action in the period on August 1, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Emocha Mobile Health Inc?
Its largest are Cardiovascular Diseases Research, Drug Use and Addiction Research Programs and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Owings Mills
Largest federal grant recipients in Maryland · Federal grants in Maryland